Medicines

Mounjaro has been an “overwhelmingly positive experience” for PharmaDoctor’s chief executive Graham Thoms, but he stresses it’s neither a “magic bullet” nor a “short-term fix” and that uniform regulation must be implemented.

The regulator has issued a year’s suspension in an “unusual case” that saw a pharmacist send prescription only medicines (POMs) “hidden in a barrel with clothes and shoes” to Sierra Leone.

The US DOJ has filed a lawsuit against CVS alleging its “actions helped to fuel the opioid crisis” as it “prioritized corporate profits over patient safety”.

Patients using weight loss drugs in the UK have overwhelmingly opted for Mounjaro over Wegovy in the last six months, PharmaDoctor data has revealed.

The pharmacy all party parliamentary group (APPG) has launched a “vital” inquiry into the impact of medicines shortages in England.

Ex-social-media-influencer Georgie Aldous, who was able to take weight loss jab Mounjaro despite suffering with an eating disorder, has warned followers that the drug is “not worth the risk”.

A pilot scheme making HIV drug pre-exposure prophylaxis (PrEP) “more accessible” via community pharmacies is set to begin in autumn 2025, the Welsh government has told C+D.

An online pharmacy has come under fire for “treating injectable medications like grocery items at a Lidl checkout”.

New analysis by the National Pharmacy Association (NPA) has found that the UK is “one of the worst countries in the OECD” for pharmacy provision.

The “first” NHS Mounjaro patients of a possible 3.4 million are set to receive the weight loss jab by March 2025, NICE has revealed in new draft guidance, while the first generic GLP-1 weight loss drug could soon follow.